Postpartum rectus abdominis dissociation
Conditions
Interventions
experimental group:NMES
control group:excise
Sponsors
Huashan Hospital Affiliated to Fudan University
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1. According to the classification standard of rectus abdominis separation, those women with rectus abdominis separation after parturition had rectus abdominis separation, and the umbilical separation was more than 3cm; 2. Patients aged 18-40 years (young women of childbearing age); 3. Subjects with negative serum or urine pregnancy test; 4. Patients with rectus abdominis separation course > 3 months < 12 months. 5. Women in childbearing period should use contraception at least one month before screening, and promise to use contraception during the whole study period and continue to use contraception until the specified time after the end of the study; 6. The subjects who promise to abide by the research procedures cooperate with the implementation of the whole process of the research and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients complicated with abdominal wall hernias such as umbilical hernia and leucocele; 2. Subjects with previous abdominal surgery (except caesarean section); 3. Patients with systemic diseases such as pregnancy induced hypertension, gestational diabetes and endocrine disorders during pregnancy; 4. Postpartum patients with cesarean section wound infection, puerperal fever, lactation mastitis and other surgical infection diseases; 5. BMI > 27.5 (obesity); 6. BMI =3; 13. Patients with HBsAg +, HIV +, TPPA +, or other infectious diseases not under control 14. Patients with long-term use of hormones (for example, rheumatic diseases and other autoimmune diseases); 15. Patients with infection or skin disease in abdominal rehabilitation site; 16. The patients and their families had poor compliance and could not cooperate with clinical treatment and follow-up; 17. Patients who could not sign the informed consent form; 18. Patients who intend to be pregnant in the study phase; 19. Patients who have received rehabilitation treatment in the past; 20. Other circumstances in which the researcher considers that the patient is not suitable to participate in the clinical trial. 21. Subjects with contraindications (1) There are electronic implanted devices (such as cardiac pacemaker or defibrillator, brain pacemaker, etc.) (2) Suffering from other cardiovascular and other diseases. (3) Other types of abdominal implants (such as metal IUDs) are being used to treat cancer, (4) Epilepsy and cognitive impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| millimeter; | — |
Countries
China
Contacts
Public ContactWu Yi
Huashan Hospital Affiliated to Fudan University
Outcome results
None listed